Cited by — Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial.
No admitted local citation edges point to this work yet.
